Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma
Open Access
- 27 September 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (43) , 6245-6249
- https://doi.org/10.1038/sj.onc.1204828
Abstract
Previous comparative genomic hybridization and allelic loss analyses demonstrated frequent deletions from 15q11.1–15 in malignant mesothelioma. Recurrent losses of 15q11–22 have also been reported in several other tumor types such as breast and colorectal cancers. To more precisely map the commonly deleted region, we have performed a high density loss of heterozygosity analysis of 46 malignant mesotheliomas, using 26 polymorphic microsatellite markers spanning the entire long arm of chromsome 15. Allelic loss from 15q was observed in 22 of 46 (48%) cases. These analyses have defined a minimally deleted region of ∼ 3-cM, which was confirmed to reside at 15q15 by fluorescence in situ hybridization analysis with yeast artificial chromosome probes. No tumor suppressor genes have been reported to map to this site. The minimally deleted region identified in this investigation overlaps those observed in other kinds of cancer, and is the smallest site of recurrent 15q loss identified to date in human tumors. The identification of this commonly deleted site implicates a putative tumor suppressor gene(s) at 15q15 involved in diverse forms of human neoplasia.Keywords
This publication has 21 references indexed in Scilit:
- New molecular and epidemiological issues in mesothelioma: Role of SV40Journal of Cellular Physiology, 1999
- Comprehensive Human Genetic Maps: Individual and Sex-Specific Variation in RecombinationAmerican Journal of Human Genetics, 1998
- Linkage Map IntegrationGenomics, 1996
- Mechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated CancersCancer Investigation, 1996
- Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogeneCytogenetic and Genome Research, 1996
- High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.Proceedings of the National Academy of Sciences, 1995
- Tumor suppressor genesNeuron, 1993
- The Waterfall IllusionAnalysis, 1988
- Familial mesothelioma: Review and family studyCancer Genetics and Cytogenetics, 1985
- The Pathogenesis of Asbestos-Associated DiseasesNew England Journal of Medicine, 1982